![Kapil Sibal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di Kapil Sibal
Precedenti posizioni note di Kapil Sibal
Società | Posizione | Inizio | Fine |
---|---|---|---|
International AIDS Vaccine Initiative, Inc.
![]() International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2002 | 01/01/2011 |
India Ministry of Communications & Information Technology | Corporate Officer/Principal | - | - |
India Ministry of Human Resources Development | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
India | 3 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Settori
Government | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
International AIDS Vaccine Initiative, Inc.
![]() International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
India Ministry of Human Resources Development | Government |
India Ministry of Communications & Information Technology | Government |
- Borsa valori
- Insiders
- Kapil Sibal
- Esperienza